FIELD: medicine, immunodiagnostics.
SUBSTANCE: the present innovation deals with detecting relapses and metastases before their clinical manifestation in patients with pulmonary cancer and matching the terms and type of anti-tumor therapy after carrying out operative removal of lesion focus. Due to reaction of passive hemagglutination one should study the level of antibodies to antigens of pulmonary cancer and at the value of 1/8 and higher it is possible to state upon the presence of either relapse or metastasis to conduct anti-tumor chemotherapy, and at the level of antibodies being ј the above-mentioned anti-tumor therapy should be abolished. The innovation enables to detect relapses and metastases at earlier stages to conduct due therapy.
EFFECT: higher accuracy of prediction.
5 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING THE CASES OF BENIGN AND MALIGNANT TUMORS | 1999 |
|
RU2154830C1 |
| METHOD OF DIAGNOSTICS OF IMPAIRED HEARING | 0 |
|
SU1332230A1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF PULMONARY ADENOCARCINOMA | 2018 |
|
RU2706116C1 |
| METHOD OF PREDICTING EFFICIENCY OF ANTITUMOUR TREATMENT | 2009 |
|
RU2411913C1 |
| METHOD FOR COMPLEX THERAPY OF PULMONARY CANCER. | 2003 |
|
RU2257218C1 |
| METHOD FOR DETERMINING THE EFFECTIVENESS OF CHEMOTHERAPY WITH PLATINUM PREPARATIONS IN III-IV STAGE OVARIAN CANCER | 2020 |
|
RU2738167C1 |
| METHOD OF TREATMENT OF LOCALLY ADVANCED LUNG CANCER | 2007 |
|
RU2348420C2 |
| METHOD OF DIAGNOSIS OF HEAD BRAIN NEW FORMATIONS | 0 |
|
SU664505A1 |
| METHOD OF TREATING ONCOLOGICAL PAIN | 2019 |
|
RU2707954C1 |
| LUNG CANCER THERAPY | 2009 |
|
RU2406452C1 |
